BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29049217)

  • 1. Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis.
    Hu B; Shi C; Jiang HX; Qin SY
    Medicine (Baltimore); 2017 Oct; 96(42):e8261. PubMed ID: 29049217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
    Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
    Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
    Liu J; Li J; Li H; Li A; Liu B; Han L
    Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening key candidate genes and pathways involved in insulinoma by microarray analysis.
    Zhou W; Gong L; Li X; Wan Y; Wang X; Li H; Jiang B
    Medicine (Baltimore); 2018 Jun; 97(22):e10826. PubMed ID: 29851790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
    Zhang H; Liu J; Fu X; Yang A
    Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
    Yang ZQ; Liu YJ; Zhou XL
    Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
    Li N; Zhao X; You S
    Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and pathways in benign prostatic hyperplasia.
    Ke ZB; Cai H; Wu YP; Lin YZ; Li XD; Huang JB; Sun XL; Zheng QS; Xue XY; Wei Y; Xu N
    J Cell Physiol; 2019 Nov; 234(11):19942-19950. PubMed ID: 31187492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the autophagy gene expression profile of pancreatic cancer based on autophagy-related protein microtubule-associated protein 1A/1B-light chain 3.
    Yang YH; Zhang YX; Gui Y; Liu JB; Sun JJ; Fan H
    World J Gastroenterol; 2019 May; 25(17):2086-2098. PubMed ID: 31114135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.